AtriCure ATRC Business Segments
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Revenue from Contract with Customer, Excluding Assessed Tax by Product | ||||||
| Appendage management | $60.01M+15.9% | $56.89M+14.7% | $55.62M+20.9% | $55.91M+20.2% | $51.77M+18.9% | |
| Minimally invasive ablation | $8.3M-20.9% | $9.85M-24.3% | $9.29M-27.4% | $10.21M-24.9% | $10.49M-27.3% | |
| Open ablation | $48.6M+14.9% | $49.32M+17.4% | $46.44M+18.5% | $46.82M+17.2% | $42.3M+13.7% | |
| Pain management | $24.35M+27.8% | $24.44M+24.4% | $22.92M+28.0% | $23.2M+42.8% | $19.06M+39.4% | |
| Revenue from Contract with Customer, Excluding Assessed Tax by Geography | ||||||
| Asia Pacific | $7.08M+4.3% | —— | —— | —— | $6.78M-0.9% | |
| Europe | $16.07M+13.2% | $15.99M+16.9% | $15.17M+24.2% | $16.13M+27.7% | $14.2M+25.1% | |
| Other International | $1.89M+27.2% | $1.8M+15.8% | $1.71M+28.6% | $1.94M+40.6% | $1.49M+53.0% | |
| Total International | $25.04M+11.5% | $26.17M+15.3% | $24.96M+22.0% | $25.56M+23.3% | $22.47M+20.8% | |
| United States | $116.21M+14.9% | $114.33M+12.6% | $109.31M+14.5% | $110.58M+15.7% | $101.15M+12.1% | |
| Long-Lived Assets by Geography | ||||||
| Europe | $6.02M+6.1% | $6.29M+56.5% | $5.89M+37.7% | $6.03M+58.8% | $5.67M+56.4% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does AtriCure break its business down?
- AtriCure (ATRC) reports revenue from contract with customer, excluding assessed tax by product across 4 parts — Appendage management, Minimally invasive ablation, Open ablation and Pain management. Each is extracted from the segment footnotes and tracked over time.
- Where does AtriCure's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in AtriCure's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
